4 Mid Cap Biotech Stocks Armed With Cash And Backed By Analysts

To lots of investors, biotech can seem like a risky bet. But what if the company has strong cash reserves? After all, having cash can fuel innovative R & D, strategic acquisitions, or long term investments, all of which could make a stock a homerun. Today we focused on biotechnology stocks that have strong cash reserves built up, and that analysts have rated positively in recent months. We came up with a pretty interesting list - we hope you like it.The Current ratio is a liquidity ratio used to determine a company's financial health. The metric illustrates how easily a firm can pay back its short obligations all at once through current assets. A company that has a current ratio of one or less is generally a liquidity red flag. Now this doesn't mean the company will go bankrupt tomorrow, but it also doesn't bode well for the company,
... Read the rest at SeekingAlpha.com